167 related articles for article (PubMed ID: 3046770)
1. An endemic focus of visceral leishmaniasis in Meshkin-Shahr, east Azerbaijan province, north-west part of Iran and IFA serological survey of the disease in this area.
Edrissian GH; Hafizi A; Afshar A; Soleiman-Zadeh G; Movahed-Danesh AM; Garoussi A
Bull Soc Pathol Exot Filiales; 1988; 81(2):238-48. PubMed ID: 3046770
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection.
Soleimanzadeh G; Edrissian GH; Movahhed-Danesh AM; Nadim A
Bull World Health Organ; 1993; 71(6):759-62. PubMed ID: 8313493
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of prevalent status of kala-azar in endemic area of Hubei Province].
Gui AF; Zuo SL; Wu JH; Gui XE; Hu LQ; Yang LD; Zhang SQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):170-2. PubMed ID: 12567700
[TBL] [Abstract][Full Text] [Related]
4. [Serological, clinical and epidemiologic analysis of 53 cases of kala-azar in the Arab Republic of Yemen].
Daoud W; Rageh HA
Bull Soc Pathol Exot Filiales; 1986; 79(4):507-13. PubMed ID: 3802310
[TBL] [Abstract][Full Text] [Related]
5. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran.
Mohebali M; Hamzavi Y; Edrissian GH; Forouzani A
East Mediterr Health J; 2001 Nov; 7(6):912-7. PubMed ID: 15332732
[TBL] [Abstract][Full Text] [Related]
7. A further study of LDT and IFAT tests in evaluating the control of kala-azar in China.
Bao Y; Wang ST; Shao QF
J Trop Med Hyg; 1994 Dec; 97(6):357-61. PubMed ID: 7966538
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
[TBL] [Abstract][Full Text] [Related]
9. Visceral leishmaniasis and malaria prevalence in West Pokot District, Kenya.
Mutero CM; Mutinga MJ; Ngindu AM; Kenya PR; Amimo FA
East Afr Med J; 1992 Jan; 69(1):3-8. PubMed ID: 1628545
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.
Ashkan MM; Rahim KM
Trop Doct; 2008 Jul; 38(3):186-8. PubMed ID: 18628558
[TBL] [Abstract][Full Text] [Related]
11. [Immunodiagnostic findings in patients with kala-azar].
Mannweiler E; Lederer I; Feldmeier H
Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
[TBL] [Abstract][Full Text] [Related]
12. Integrated visceral leishmaniasis surveillance system in primary care for children in Meshkin-Shahr district, north-western Islamic Republic of Iran.
Mohebali M; Edrissian GH; Shirzadi MR; Hosseingholizadeh G; Pashaei MH; Ganji A; Zarei Z; Kousha A; Akhoundi B; Hajjaran H; Malekafzali H
East Mediterr Health J; 2010 Oct; 16(10):1050-4. PubMed ID: 21222421
[TBL] [Abstract][Full Text] [Related]
13. Relevance of direct agglutination test in seroepidemiological survey of Kala-azar in epidemic foci of Bihar.
Sharma MC; Bimal S; Ranjan A; Das VN; Gupta AK; Kumar N; Kar SK
J Commun Dis; 2000 Jun; 32(2):117-22. PubMed ID: 11198396
[TBL] [Abstract][Full Text] [Related]
14. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
Karp CL; Turco SJ; Sacks DL
J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological, clinical and therapeutic features of pediatric kala-azar.
Rahim KM; Ashkan MM
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):626-30. PubMed ID: 17882998
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic problems of kala azar in non-endemic area.
Datta U; Gupta S; Arora S; Sehgal S
Indian J Pathol Microbiol; 1987 Jan; 30(1):23-9. PubMed ID: 3315993
[No Abstract] [Full Text] [Related]
17. Visceral leishmaniasis (kala-azar) in Fars Province, Iran: study of 130 cases.
Hashemi-Nasab A; Zadeh-Shirazi H
J Trop Med Hyg; 1980 Jun; 83(3):119-22. PubMed ID: 7401218
[TBL] [Abstract][Full Text] [Related]
18. [Results of the serological examination of the population in the suppressed focus of human cutaneous leishmaniasis (Kirovabad, Azerbaijan SSR)].
Gasanzade GB; Faramazov AZ; Shal'miev GB; Mamedova FM; Nemchinova LI
Med Parazitol (Mosk); 1987; (1):60-2. PubMed ID: 2952870
[No Abstract] [Full Text] [Related]
19. [Visceral leishmaniasis contracted in Europe (kala-azar)].
Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
[No Abstract] [Full Text] [Related]
20. Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal.
Khanal B; Picado A; Bhattarai NR; Van Der Auwera G; Das ML; Ostyn B; Davies CR; Boelaert M; Dujardin JC; Rijal S
Parasitology; 2010 Sep; 137(11):1597-603. PubMed ID: 20459877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
